New Spero hires get stock awards, but vesting starts after a year
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Spero Therapeutics announced that its Compensation Committee approved grants of 233,000 restricted stock units (RSUs) and 323,000 stock options to new employees on October 1, 2026. These inducement grants are made under the 2019 Inducement Equity Incentive Plan, in accordance with Nasdaq Listing Rule 5635(c)(4). The awards vest over multiple years, with vesting beginning on the first anniversary of each employee's start date and requiring continued employment.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.